发明名称 The modulation of hyaluronan synthesis and degradation in the treatment of disease
摘要 Disclosed is an isolated nucleic acid based compound which reduces the level of hyaluronan synthase (HAS) activity wherein said compound specifically targets a nucleic acid molecule encoding SEQ ID NOs:24, 25 or 26 or encoding a sequence containing one or more conservative amino acid substitutions of SEQ ID NOs:24, 25 or 26, wherein said nucleic acid based compound is selected from an anti-sense molecule, a sense molecule, an siRNA, a dsRNA, an RNAi, a ribozyme, an oligomeric compound, an oligonucleotide and a DNAzyme.
申请公布号 NZ546272(A) 申请公布日期 2009.05.31
申请号 NZ20040546272 申请日期 2004.10.11
申请人 ALCHEMIA ONCOLOGY PTY LIMITED 发明人 BROWN, TRACEY JEAN;BROWNLEE, GARY RUSSELL
分类号 A61K31/395;A61K31/7105;A61K31/711;A61K31/7115;A61K31/712;A61K31/7125;A61P35/00;C07H21/02;C07H21/04;C07K16/40;(IPC1-7):C07H21/04;A61K31/710 主分类号 A61K31/395
代理机构 代理人
主权项
地址